Skip to Main Content

Haemophilus influenza organism
Haemophilus influenza organism
Haemophilus influenza organism
Haemophilus influenza organism
Hib immunization (vaccine)
Hib immunization (vaccine)

Hib - vaccine

Definition:

This vaccine (immunization) prevents childhood Haemophilus influenza B infections, which can cause a severe and potentially fatal illness.





Alternative Names:
Haemophilus influenzae type B (Hib) vaccine; Vaccine - Hib; Haemophilus influenzae B conjugate vaccine



Information:

VACCINE INFORMATION

The Hib vaccine is highly effective for the prevention of diseases caused by Hib, which are serious, potentially fatal diseases of childhood.

IMMUNIZATION SCHEDULE

Haemophilus b conjugate vaccine is one of the recommended childhood immunizations. Generally, states require proof that a child has received the vaccine prior to entry into daycare or preschool.

  • Infants and toddlers should receive injections of the vaccine at 2 months, 4 months, 6 months, and 12-15 months of age.
  • Children over 5 years of age and adults do not need to receive immunization for Haemophilus influenzae type b unless they have certain medical conditions, including HIV, sickle cell disease, and some others -- consult with your doctor about whether this applies to your child if he/she has not been vaccinated.
BENEFITS

Hib vaccine has been a great public health success story. The vast majority of infants receiving 3 doses of the Hib vaccine gain long-term protection against the illnesses caused by Haemophilus b bacteria. These illnesses include meningitis, pneumonia, and infections of the blood, bones, and joints. Serious Haemophilus b infections are most common in children 6 to 12 months old, but may also occur in older children.



RISKS

Most infants who receive the Hib vaccine will have no associated problems. Others may have minor problems, such as soreness and redness at the injection site or a mild fever. Serious problems associated with receiving the immunization are rare and are mainly allergic reactions to vaccine components.



DELAY OR DO NOT GIVE (CONTRAINDICATION)
  • If the child is ill, with something more serious than a cold, immunizations may be delayed.
  • If severe allergic reaction or anaphylaxis occurs after an injection of the Hib vaccine, no further Haemophilus b immunization should be given to the child.
  • There are no other specific contraindications to the Hib vaccine for infants or young children except the Hib vaccine should not be given to children less than 6 weeks of age.
POSTIMMUNIZATION SYMPTOMS AND CARE

Watch for and be familiar with how to treat minor side effects, such as injection site tenderness or low-grade fever.



CALL THE PRIMARY HEALTH CARE PROVIDER IF:
  • uncertain if the Haemophilus b vaccine should be delayed, withheld, or given to a specific infant.
  • moderate or serious adverse effects appear after the Hib injection has been given.
  • there are any questions or concerns related to the Haemophilus b immunization.




Review Date: 7/29/2002

Reviewed By: Adam Ratner, M.D., Children's Hospital of Philadelphia, Philadelphia, PA. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).


The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.



HealthDay News

New Drug-Coated Stent Approved

SIDS Linked to Brain Chemical Dysfunction

Lots of Sex May Prevent Erectile Dysfunction

Health Highlights: July 3, 2008

HealthDay is a national consumer news and information company and the information it provides may not be consistent with the teachings of the Catholic Church. Avera Health, a ministry of the Catholic Church, does not recommend, endorse or offer procedures or interventions that are contrary to those teachings.

Your Personal Health Record

Access to your personal health information is critical to ensuring you receive timely, safe, and effective treatment and care. Learn more at MyPHR.com, a public resource designed to help you understand your personal health information.